PL2526422T3 - Sposób diagnozowania choroby Sjogrena - Google Patents

Sposób diagnozowania choroby Sjogrena

Info

Publication number
PL2526422T3
PL2526422T3 PL11735215T PL11735215T PL2526422T3 PL 2526422 T3 PL2526422 T3 PL 2526422T3 PL 11735215 T PL11735215 T PL 11735215T PL 11735215 T PL11735215 T PL 11735215T PL 2526422 T3 PL2526422 T3 PL 2526422T3
Authority
PL
Poland
Prior art keywords
disease
diagnosing sjogren
sjogren
diagnosing
Prior art date
Application number
PL11735215T
Other languages
English (en)
Inventor
Julian L. Ambrus Jr.
Long Shen
Original Assignee
The Research Foundation Of State University Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Research Foundation Of State University Of New York filed Critical The Research Foundation Of State University Of New York
Publication of PL2526422T3 publication Critical patent/PL2526422T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/988Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
PL11735215T 2010-01-21 2011-01-21 Sposób diagnozowania choroby Sjogrena PL2526422T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29716710P 2010-01-21 2010-01-21

Publications (1)

Publication Number Publication Date
PL2526422T3 true PL2526422T3 (pl) 2017-01-31

Family

ID=44307219

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11735215T PL2526422T3 (pl) 2010-01-21 2011-01-21 Sposób diagnozowania choroby Sjogrena

Country Status (9)

Country Link
US (2) US8765387B2 (pl)
EP (1) EP2526422B1 (pl)
AU (1) AU2011207296B2 (pl)
CA (1) CA2787973C (pl)
DK (1) DK2526422T3 (pl)
ES (1) ES2587994T3 (pl)
PL (1) PL2526422T3 (pl)
PT (1) PT2526422T (pl)
WO (1) WO2011091220A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180298094A1 (en) * 2017-04-17 2018-10-18 Ksl Biomedical Llc Monoclonal antibodies targeted to human taxilin alpha and methods for use of same
WO2024076801A2 (en) * 2022-08-09 2024-04-11 Wisconsin Alumni Research Foundation Novel auto-antibodies and method to detect sjögren's disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895812A (en) * 1995-05-01 1999-04-20 The University Of Virginia Alumni Patent Foundation Diagnostic for Sjogren's syndrome
RO114835B1 (ro) * 1997-03-17 1999-07-30 Ioan Puşcaş Metodă rapidă de diagnostic al cancerelor
DE19939575C1 (de) * 1999-08-20 2001-08-02 Orgentec Diagnostika Gmbh Verfahren zur Diagnose von Sjögren-Syndrom
WO2007062363A2 (en) * 2005-11-18 2007-05-31 Large Scale Biology Corporation Method for diagnosing a person having sjogren's syndrome
US8320286B2 (en) 2007-03-09 2012-11-27 Broadcom Corporation Infrastructure offload wake on wireless LAN (WOWL)
US7925795B2 (en) 2007-04-30 2011-04-12 Broadcom Corporation Method and system for configuring a plurality of network interfaces that share a physical interface
US8569449B2 (en) * 2007-05-08 2013-10-29 University Of Louisville Research Foundation, Inc. Synthetic peptides and peptide mimetics
US8879570B2 (en) 2009-09-04 2014-11-04 Brocade Communications Systems, Inc. Systems and methods for reconfiguring a network adapter in sleep mode

Also Published As

Publication number Publication date
US20130040322A1 (en) 2013-02-14
ES2587994T3 (es) 2016-10-28
US8765387B2 (en) 2014-07-01
AU2011207296A1 (en) 2012-08-23
US20140255955A1 (en) 2014-09-11
CA2787973A1 (en) 2011-07-28
AU2011207296B2 (en) 2016-05-26
DK2526422T3 (en) 2016-09-05
CA2787973C (en) 2020-07-14
US9012158B2 (en) 2015-04-21
PT2526422T (pt) 2016-08-23
EP2526422A1 (en) 2012-11-28
EP2526422B1 (en) 2016-05-25
EP2526422A4 (en) 2013-06-19
WO2011091220A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
HK1225970A1 (zh) 利用拉喹莫德治療亨廷頓氏病
IL230034B (en) MicroRNA biomarkers that indicate Alzheimer's disease
GB2473392B (en) Methods of diagnosis
EP2435097A4 (en) COMPOUNDS CONTAINING TRIMETHYLAMINE IN DIAGNOSIS AND PREDICTION OF DISEASE
IL230441A0 (en) Diagnosis of Alzheimer's disease
IL231620A0 (en) A method for diagnosing Alzheimer's disease
ZA201404500B (en) Methods for diagnosing alzheimer's disease
EP2788034A4 (en) SPECTRAL IMAGING RADIOMETRY FOR EARLY DETECTION OF ALZHEIMER'S DISEASE
HK1159245A1 (en) Diagnosis of an asthma disease state
ZA201302402B (en) Methods for diagnosing lyme disease
IL229607B (en) A method for diagnosing Gaucher's disease
EP2544686A4 (en) COMBINED METHODS FOR THE TREATMENT OF DISEASES
EP2440927A4 (en) METHOD AND SYSTEM FOR DETECTING, DIAGNOSING AND MONITORING THE PROGRESSION OF ALZHEIMER'S DISEASE
GB201021397D0 (en) Diagnosis of Crohn's disease
EP2791676A4 (en) PROCESS FOR THE DIAGNOSIS OF MORBUS ALZHEIMER
EP2906225A4 (en) METHODS OF TREATING KENNEDY'S DISEASE
EP2660600A4 (en) DIAGNOSTIC MEDICINE AND DIAGNOSTIC METHOD FOR ALZHEIMER'S DISEASE
EP2631646A4 (en) BIOMARKER FOR MORBUS ALZHEIMER OR LIGHT COGNITIVE IMPAIRMENT
EP2526422A4 (en) METHOD FOR DIAGNOSIS OF THE SJÖGREN SYNDROME
EP2580593A4 (en) DIAGNOSIS OF MYOCARDIAL AUTOIMMUNITY IN HEART DISEASES
FR2959904B1 (fr) Procede d'imagerie
HU0900199D0 (en) Diagnosis of gluten-induced autoimmune diseases
GB0903858D0 (en) Diagnosis of disease
AP2013006853A0 (en) Biomarker for vavular heart disease
GB0917326D0 (en) Diagnosis of alzheimer's disease